Angina Market Poised for 6.1 % Growth, Set to Hit $1.72 Billion by 2029

What combination of drivers is leading to accelerated growth in the angina market?
The growth of the angina market is anticipated to be driven by the increasing instances of coronary artery diseases. Known as coronary heart disease (CHD) or ischemic heart disease (IHD) as well, coronary artery disease (CAD) is a condition marked by the constriction or obstruction of the coronary arteries delivering blood, oxygen, and nutrients to the cardiac muscle. The rising incidence of CAD can be attributed to shifts in lifestyle and environmental and genetic factors. Angina has a crucial part in detecting and comprehending the prevalence of CAD. Its existence triggers medical assessment and diagnosis, aids in risk stratification, influences therapeutic choices, and steers public health tactics. As per the American Heart Association, the CAD-affected adult population in the U.S. increased from 18.2 million to an estimated 19.3 million between 2021 and 2022. Consequently, the escalating instances of coronary artery diseases are propelling the angina market.

Get Your Angina Market Report Here:
https://www.thebusinessresearchcompany.com/report/angina-global-market-report

What is the projected compound annual growth rate (CAGR) of the angina market from 2025 to 2034, and what factors influence it?
The market size for angina has experienced robust growth in the past few years. The projected increase is from $10.71 billion in 2024 to $11.4 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the historic period include a higher frequency of coronary heart disease, greater utilization of vasodilators, an increased incidence of myocardial ischemia, advancements in diagnostic abilities, and a rise in the application of imaging techniques.

Over the coming years, the angina market size is projected to experience robust growth, increasing to $14.44 billion by 2029 with a compound annual growth rate (CAGR) of 6.1%. Factors propelling the growth during the forecast period include the rising incidence of chronic angina pectoris, increased drug approvals and clinical studies, growing demand in retail pharmacies, heightened awareness of cardiovascular health, and an escalating demand for medications. Foreseen trends within the forecast period encompass advancements in early diagnosis technology, developments in angioplasty and stenting procedures, innovative gene therapy methodologies, increased demand for coronary stents, and progress in treatments for coronary artery disease.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

How are the latest trends influencing the growth of the angina market?
Leading firms in the angina market are focusing on the creation of revolutionary drugs such as metoprolol tartrate tablets, a novel approach in providing more efficacious and patient-centered treatments for coronary artery disease (CAD) and other related conditions. Metoprolol tartrate tablets, widely known as effective treatment for different cardiovascular issues like angina, hypertension and heart failure, are of growing appeal. For instance, in April 2023, Zydus, a renowned pharmaceutical company based in India, secured the final nod from the United States Food and Drug Administration (US-FDA) to produce and sell its generic equivalent of Metoprolol Tartrate Tablets USP in dosages of 25 mg, 50 mg, and 100 mg. Metoprolol, a beta blocker, is typically used to address various cardiovascular ailments, including hypertension and angina, and to enhance survival rates post a cardiac arrest.

What are the major segments of the angina market and their role in driving growth?
The angina market covered in this report is segmented -

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types
2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments
3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes
4) By Application: Clinics, Hospitals, Other Applications

Subsegments:
1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina
2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina
3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina
4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16337

Which regions are key players in the growth of the angina market?
North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the angina market?
Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy's Laboratories, ViroMed Co. Ltd., Lee's Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=16337&type=smp

What Is Covered In The Angina Global Market Report?

•Market Size Forecast: Examine the angina market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the angina market for a structured understanding.
•Key Players Overview: Analyze major players in the angina market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the angina market.
•Segment Contributions: Evaluate how different segments drive overall growth in the angina market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the angina market.
•Industry Challenges: Identify potential risks and obstacles affecting the angina market.
•Competitive Landscape: Review strategic developments in the angina market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.